A CRISPR-Cas12a-based platform for ultrasensitive rapid highly specific detection of Mycobacterium tuberculosis in clinical application.
Front Cell Infect Microbiol
; 13: 1192134, 2023.
Article
in En
| MEDLINE
| ID: mdl-37287467
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Tuberculosis
/
COVID-19
/
Mycobacterium tuberculosis
Type of study:
Diagnostic_studies
Limits:
Humans
Language:
En
Journal:
Front Cell Infect Microbiol
Year:
2023
Document type:
Article
Affiliation country: